Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NexgenRx Announces First Quarter of 2015 Results

V.NXG

TORONTO, ONTARIO--(Marketwired - May 25, 2015) - NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) is pleased to announce its first quarter of 2015 results.

For the first quarter ended March 31, 2015 transaction and administration revenue was $1,201,317, generating gross profit of $966,807 and a net income of $4,560.

"Our sales team is committed to the growth and we see a reflection of this commitment in our Q1, 2015 profitable results along with confirmed new sales for Q2 and Q3. We generated an increase in Q1 revenue of 16% and an increase in gross profit of 18% compared to the same period in 2014." stated Ron Loucks, President and CEO.

About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. More information on NexgenRx can be found at www.nexgenrx.com.

Caution Regarding Forward-Looking Statements - This news release contains certain forward looking statements, including statements regarding the business and anticipated financial performance of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements.

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release."

NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801

NexgenRx Inc.
Taba Merrikh
Director of Finance
416-695-3393 x803
www.nexgenrx.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today